细胞外容积分数与结局的关联强于原生或增强后心肌T1
在1714例无淀粉样变性或肥厚型心肌病的连续患者中,比较细胞外容积分数(ECV)、原生T1、增强后T1及分配系数与非梗死心肌纤维化相关结局的关联;中位随访5.6年,ECV与结局关联最强,原生T1或增强后T1在多变量模型中与结局无关联。
要点
- 在非梗死心肌中,ECV对结局的区分能力优于原生T1、增强后T1和分配系数。
- 多变量模型中,原生T1或增强后T1与结局无关联,而ECV与结局关联最强。
- ECV在原生T1基础上提供增量预后价值:IDI=0.0037(95%CI 0.0009-0.0071),NRI=0.151(95%CI 0.022-0.292)。
核心结论
- ECV心肌纤维化指标与结局的关联比原生T1、增强后T1等其他替代CMR纤维化指标更稳健,支持ECV是量化非梗死心肌纤维化的最优指标。
研究设计与样本
- 单中心连续纳入1714例无淀粉样变性或肥厚型心肌病的患者,采用MOLLI序列在基底和中段2个短轴层面于钆对比剂团注前及后15-20分钟测量T1,以Cox回归模型比较各CMR纤维化指标与结局的关联。
关键影像表现/征象
- ECV在Kaplan-Meier曲线中给出最佳分离,log-rank统计量最高。
- 单变量和多变量模型中,ECV与结局关联最强,卡方检验值最高。
- 原生T1或增强后T1在多变量模型中与结局无关联。
诊断标准与关键数值
- ECV在原生T1基础上提供增量预后价值:多变量模型IDI=0.0037(95%CI 0.0009-0.0071),p=0.02;NRI=0.151(95%CI 0.022-0.292),p=0.04。
临床应用与阅片要点
- 在非梗死心肌纤维化评估中,ECV对结局的区分能力优于原生T1、增强后T1和分配系数。
- 多变量模型中原生T1或增强后T1与结局无关联,ECV与结局关联最强。
局限性
- 单中心研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Because risk stratification data represents a key domain of biomarker validation, we compared associations between outcomes and various cardiovascular magnetic resonance (CMR) metrics quantifying myocardial fibrosis (MF) in noninfarcted myocardium: extracellular volume fraction (ECV), native T1, post-contrast T1, and partition coefficient.
BACKGROUND: MF associates with vulnerability to adverse events (e.g., mortality and hospitalization for heart failure [HHF]), but investigators still debate its optimal measurement; most histological validation data show strongest ECV correlations with MF.
METHODS: We enrolled 1,714 consecutive patients without amyloidosis or hypertrophic cardiomyopathy from a single CMR referral center serving an integrated healthcare network. We measured T1 (MOdified Look-Locker Inversion recovery [MOLLI]) in nonenhanced myocardium, averaged from 2 short-axis slices (basal and mid) before and 15 to 20 min after a gadolinium contrast bolus. We compared chi-square test values from CMR MF measures in univariable and multivariable Cox regression models. We assessed "dose-response" relationships in Kaplan-Meier curves using log-rank statistics for quartile strata. We also computed net reclassification improvement (NRI) and integrated discrimination improvement (IDI for Cox models with ECV vs. native T1).
RESULTS: Over a median of 5.6 years, 374 events occurred after CMR (162 HHF events and 279 deaths, 67 with both). ECV yielded the best separation of Kaplan-Meier curves and the highest log-rank statistics. In univariable and multivariable models, ECV associated most strongly with outcomes, demonstrating the highest chi-square test values. Native T1 or post-contrast T1 did not associate with outcomes in the multivariable model. ECV provided added prognostic value to models with native T1, for example, in multivariable models IDI = 0.0037 (95% confidence interval [CI]: 0.0009 to 0.0071), p = 0.02; NRI = 0.151 (95% CI: 0.022 to 0.292), p = 0.04.
CONCLUSIONS: Analogous to histological previously published validation data, ECV myocardial fibrosis measures exhibited more robust associations with outcomes than other surrogate CMR MF measures. Superior risk stratification by ECV supports claims that ECV optimally measures MF in noninfarcted myocardium.
引用
- Treibel TA, Fridman Y, Bering P, et al. Extracellular Volume Associates With Outcomes More Strongly Than Native or Post-Contrast Myocardial T1. JACC Cardiovasc Imaging. 2019. PMID: 31103587. doi:10.1016/j.jcmg.2019.03.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。